Helicos BioSciences (HLCS) Names Lowy as CEO
Helicos BioSciences (NASDAQ: HLCS) announced today that its Board of Directors has appointed Ronald Lowy as the company's CEO, effective immediately.
Helicos BioSciences Corporation, a life sciences company, engages in the development of genetic analysis technologies for the research, drug discovery, and clinical diagnostics markets.
Helicos BioSciences Corporation, a life sciences company, engages in the development of genetic analysis technologies for the research, drug discovery, and clinical diagnostics markets.
You May Also Be Interested In
- AK Steel (AKS) Promotes Four to VP, SVP; Names New Raw Materials Engineering VP
- Knight Transportation (KNX) Appoints Adam Miller as CFO; Names New Director
- Canaccord Genuity Morning Coffee on Cree (CREE) and Extreme Networks (EXTR): Shedding Some Light On The Situation
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
